Efficacy and Safety of Fat-Derived Autologous Expanded Mesenchymal Stem Cell Therapy for the Management of Musculoskeletal Conditions: A 5-Year Experience

Journal of Orthopaedic Science and Research Pub Date : 2022-09-06 DOI:10.46889/josr.2022.3301

H. Mubark

引用次数: 0

Abstract

This editorial addresses the efficacy of single or repeated fat-derived autologous expanded Mesenchymal Stem Cell (MSC) therapy for orthopaedic conditions, specifically degenerative and injury-related joint and soft tissue disorders.

查看原文本刊更多论文

脂肪来源的自体间充质干细胞治疗肌肉骨骼疾病的有效性和安全性:5年的经验

这篇社论讨论了单一或重复脂肪来源的自体间充质干细胞(MSC)治疗骨科疾病的疗效，特别是退行性和损伤相关的关节和软组织疾病。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Orthopaedic Science and Research

自引率

0.00%

发文量